Table 3

Correlations between LFA-REAL ClinRO and PRO scores, ClinRO rash and PRO rash, ClinRO alopecia and PRO hair loss, ClinRO arthralgia/arthritis and PRO overall arthritis at baseline, week 24 and week 52 visits as well as change from baseline to week 24 and week 52

	At visit			Change from baseline
	Baseline	Week 24	Week 52	Week 24	Week 52
ClinRO arthralgia/arthritis and PRO overall arthritis	0.38	0.49	0.56	0.24	0.37
ClinRO alopecia and PRO hair loss	0.38	0.50	0.61	0.38	0.30
ClinRO rash and PRO rash	0.51	0.49	0.66	0.43	0.49
ClinRO total and PRO total	0.32	0.45	0.50	0.27	0.37

Correlation scale very weak: 0–0.2; weak: 0.2–0.4; moderate: 0.4–0.6; strong: 0.6–0.8; very strong: 0.8–1.0. P≤0.015 across all correlation analyses.
ClinRO, clinician-reported outcomes; LFA-REAL, Lupus Foundation of America Rapid Evaluation of Activity in Lupus; PRO, patient-reported outcomes.